Immune Mechanisms in Thyroid Eye Disease
- 1 September 2008
- journal article
- review article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 18 (9), 959-965
- https://doi.org/10.1089/thy.2007.0407
Abstract
Thyroid eye disease (TED) is an inflammatory condition of the orbit closely associated with Graves' disease. During the course of TED, fibrosis can develop around the extraocular muscles, and excess extracellular matrix and fat accumulates in the periorbital space. This dramatic remodeling results in protrusion of the eye, also known as exophthalmos. Current treatments are sometimes effective in alleviating the symptoms of the disease, but there remains a demand for treatments that prevent or reverse the pathological alterations of orbital tissues. Such treatments may become available as a result of research aimed at understanding the mechanism by which Graves' disease leads to specific remodeling of orbital tissues. Recent findings have uncovered the importance of intercellular communication between autoreactive T cells and orbital fibroblasts. When orbital fibroblasts are activated, possibly by Graves' disease–related autoantibodies, they release T cell chemoattractants, initiating an interaction in which these cells activate each other. These interactions ultimately result in fibroblasts expressing extracellular matrix molecules, proliferating and differentiating into myofibroblasts or lipofibroblasts. Although the mechanisms underlying these processes are not completely understood, several currently available therapeutic strategies might interrupt the signaling between B and T cells and fibroblasts, thereby treating the clinical manifestations of TED.Keywords
This publication has 77 references indexed in Scilit:
- Interleukin (IL)-23 Receptor Is a Major Susceptibility Gene for Graves’ Ophthalmopathy: The IL-23/T-helper 17 Axis Extends to Thyroid AutoimmunityJournal of Clinical Endocrinology & Metabolism, 2008
- Pathogenesis of Graves' Ophthalmopathy: The Role of AutoantibodiesThyroid®, 2007
- Activated Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins that Drive Human Orbital Fibroblast Differentiation to AdipocytesThe American Journal of Pathology, 2006
- The Extrapulmonary Origin of Fibroblasts: Stem/Progenitor Cells and BeyondProceedings of the American Thoracic Society, 2006
- Peroxisome proliferator-activated receptor ligands in atherosclerosisExpert Opinion on Investigational Drugs, 2004
- Orbital Fibroblast Heterogeneity May Determine the Clinical Presentation of Thyroid-Associated OphthalmopathyJournal of Clinical Endocrinology & Metabolism, 2002
- Prevalence and Significance of Antibodies Reactive with Eye Muscle Membrane Antigens in Sera from Patients with Graves' Ophthalmopathy and Other Thyroid and Nonthyroid DiseasesThyroid®, 1998
- CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation ModelImmunological Reviews, 1996
- Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigensJournal of Clinical Endocrinology & Metabolism, 1996
- Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathyEuropean Journal of Clinical Investigation, 1993